Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 8, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
MilliporeSigma Launches AAW Workstation to Streamline Lab Automation and Boost Scientific Productivity
Life Sciences Times
-
July 15, 2025
0
Pharma
Vertex Secures NHS England Reimbursement Deal for ALYFTREK, Expanding Access to Cystic Fibrosis Treatment
Life Sciences Times
-
July 15, 2025
0
Venture Capital
Fellow Health Secures $24 Million in Series B Funding to Expand At-Home Male Fertility Testing
Life Sciences Times
-
July 15, 2025
0
People on the Move
Overture Life Appoints Matt Combs as Chief Commercial Officer to Drive Global IVF Automation Expansion
Life Sciences Times
-
July 15, 2025
0
Pharma
Shorla Oncology Receives FDA Orphan Drug Designation for SH-110 to Treat Glioma
Life Sciences Times
-
July 15, 2025
0
Pharma
Enveric Biosciences Reports Positive Preclinical Results for PTSD Drug Candidate EB-003
Life Sciences Times
-
July 15, 2025
0
Biotech
Spear Bio Partners with Bio-Techne to Expand Access to Next-Generation Immunoassay Technology
Life Sciences Times
-
July 15, 2025
0
Biotech
GelSight Launches Modulus, a Portable Device for Surface Inspection in Hard-to-Reach Areas
Life Sciences Times
-
July 15, 2025
0
Venture Capital
Waters Acquires Halo Labs to Strengthen Biologic Therapy Testing Capabilities
Life Sciences Times
-
July 14, 2025
0
Pharma
FDA Approves Bayer’s KERENDIA® for Heart Failure Patients With Preserved Ejection Fraction
Life Sciences Times
-
July 14, 2025
0
1
...
149
150
151
...
836
Page 150 of 836
Most Popular
WHOOP Expands Health Platform With Clinician Access and AI Features
May 8, 2026
Reprieve Cardiovascular Reports Published Pilot Trial Results for Heart Failure Therapy
May 8, 2026
Stoke Therapeutics Advances Dravet Syndrome Drug as Phase 3 Study Nears Enrollment Goal
May 8, 2026
Myomo Revenue Rises as Company Expands Recurring Patient Sources
May 8, 2026
Load more
Recent Comments
Recent Comments